These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 32060494)

  • 1. Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.
    Louca P; Menni C; Padmanabhan S
    Am J Hypertens; 2020 May; 33(6):473-481. PubMed ID: 32060494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missing Heritability of Hypertension and Our Microbiome.
    Marques FZ
    Circulation; 2018 Oct; 138(14):1381-1383. PubMed ID: 30354349
    [No Abstract]   [Full Text] [Related]  

  • 3. Guidelines for Transparency on Gut Microbiome Studies in Essential and Experimental Hypertension.
    Marques FZ; Jama HA; Tsyganov K; Gill PA; Rhys-Jones D; Muralitharan RR; Muir J; Holmes A; Mackay CR
    Hypertension; 2019 Dec; 74(6):1279-1293. PubMed ID: 31679421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omics in gut microbiome analysis.
    Whon TW; Shin NR; Kim JY; Roh SW
    J Microbiol; 2021 Mar; 59(3):292-297. PubMed ID: 33624266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of gut microbial metabolism on cardiovascular disease.
    Kasahara K; Rey FE
    Curr Opin Microbiol; 2019 Aug; 50():64-70. PubMed ID: 31693963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases.
    Xu J; Yang Y
    Gut Microbes; 2021; 13(1):1936379. PubMed ID: 34170211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for a link between gut microbiota and hypertension in the Dahl rat.
    Mell B; Jala VR; Mathew AV; Byun J; Waghulde H; Zhang Y; Haribabu B; Vijay-Kumar M; Pennathur S; Joe B
    Physiol Genomics; 2015 Jun; 47(6):187-97. PubMed ID: 25829393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of gut microbiome and intestinal epithelial barrier dysfunction in patients with high blood pressure.
    Kim S; Goel R; Kumar A; Qi Y; Lobaton G; Hosaka K; Mohammed M; Handberg EM; Richards EM; Pepine CJ; Raizada MK
    Clin Sci (Lond); 2018 Mar; 132(6):701-718. PubMed ID: 29507058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrigenomics, the Microbiome, and Gene-Environment Interactions: New Directions in Cardiovascular Disease Research, Prevention, and Treatment: A Scientific Statement From the American Heart Association.
    Ferguson JF; Allayee H; Gerszten RE; Ideraabdullah F; Kris-Etherton PM; Ordovás JM; Rimm EB; Wang TJ; Bennett BJ;
    Circ Cardiovasc Genet; 2016 Jun; 9(3):291-313. PubMed ID: 27095829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cross-talk between gut microbiome, salt and hypertension.
    Naqvi S; Asar TO; Kumar V; Al-Abbasi FA; Alhayyani S; Kamal MA; Anwar F
    Biomed Pharmacother; 2021 Feb; 134():111156. PubMed ID: 33401080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microbiome as a possible target to prevent celiac disease.
    Leonard MM; Fasano A
    Expert Rev Gastroenterol Hepatol; 2016; 10(5):555-6. PubMed ID: 26999627
    [No Abstract]   [Full Text] [Related]  

  • 12. Synergistic Association of Genetic Variants with Environmental Risk Factors in Susceptibility to Essential Hypertension.
    Sousa AC; Mendonça MI; Pereira A; Gouveia S; Freitas AI; Guerra G; Rodrigues M; Henriques E; Freitas S; Borges S; Pereira D; Brehm A; Palma Dos Reis R
    Genet Test Mol Biomarkers; 2017 Oct; 21(10):625-631. PubMed ID: 28872890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia.
    Clos-Garcia M; Andrés-Marin N; Fernández-Eulate G; Abecia L; Lavín JL; van Liempd S; Cabrera D; Royo F; Valero A; Errazquin N; Vega MCG; Govillard L; Tackett MR; Tejada G; Gónzalez E; Anguita J; Bujanda L; Orcasitas AMC; Aransay AM; Maíz O; López de Munain A; Falcón-Pérez JM
    EBioMedicine; 2019 Aug; 46():499-511. PubMed ID: 31327695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Overview of Metabolic Phenotyping in Blood Pressure Research.
    Tzoulaki I; Iliou A; Mikros E; Elliott P
    Curr Hypertens Rep; 2018 Jul; 20(9):78. PubMed ID: 29992526
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The unique composition of Indian gut microbiome, gene catalogue, and associated fecal metabolome deciphered using multi-omics approaches.
    Dhakan DB; Maji A; Sharma AK; Saxena R; Pulikkan J; Grace T; Gomez A; Scaria J; Amato KR; Sharma VK
    Gigascience; 2019 Mar; 8(3):. PubMed ID: 30698687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human gut microbiome and its dysfunctions through the meta-omics prism.
    Mondot S; Lepage P
    Ann N Y Acad Sci; 2016 May; 1372(1):9-19. PubMed ID: 26945826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond genomics: understanding exposotypes through metabolomics.
    Rattray NJW; Deziel NC; Wallach JD; Khan SA; Vasiliou V; Ioannidis JPA; Johnson CH
    Hum Genomics; 2018 Jan; 12(1):4. PubMed ID: 29373992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism?
    Jama HA; Beale A; Shihata WA; Marques FZ
    Cardiovasc Res; 2019 Jul; 115(9):1435-1447. PubMed ID: 30951169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omics of Blood Pressure and Hypertension.
    Arnett DK; Claas SA
    Circ Res; 2018 May; 122(10):1409-1419. PubMed ID: 29748366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome and hypertension: where are we now?
    Vallianou NG; Geladari E; Kounatidis D
    J Cardiovasc Med (Hagerstown); 2020 Feb; 21(2):83-88. PubMed ID: 31809283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.